Directly from the USA: Subclinical CVD Linked to Increased Risk for Mortality in Diabetes
Directly from the USA: Subclinical CVD Linked to Increased Risk for Mortality in Diabetes
For adults with diabetes, subclinical cardiovascular disease (CVD), as assessed by cardiac biomarkers, is associated with an increased risk for all-cause and CVD mortality, according to a study published online May 31 in the Journal of the American Heart Association.
Michael Fang, Ph.D., from the Johns Hopkins Bloomberg School of Public Health in Baltimore, and colleagues estimated the prevalence of elevated high-sensitivity cardiac troponin T (hs-cTnT; ≥14 ng/L) and N-terminal pro-B-type natriuretic peptide (NT-proBNP; ≥125 pg/mL) in 10,304 U.S. adults without a history of CVD, with and without diabetes.
Source: Advances and More licensed by HealthDay
https://advancesandmore.com/advances_article.htm?id=2660714967&client=BEE80FAF§ion=undefined
